Literature DB >> 24302513

The prevalence of Os acromiale: a systematic review and meta-analysis.

Kaissar Yammine1.   

Abstract

Os acromiale (OA) results from a failure of consolidation between the ossification centers of the acromial epiphysis. Its prevalence and its interactions with ancestry, gender, laterality, and side have been variously reported in the literature. The aims of this review are to provide an accurate estimate of OA prevalence and to investigate its association with other variables in an attempt to comprehend its etiology. Twenty-three studies met the inclusion criteria. The results of meta-analyses of large-sample studies revealed: (a) a crude overall prevalence of 7.0%, (b) a crude cadaveric prevalence of 7.6%, (c) a crude archeological (skeletal) prevalence of 5.6%, (d) a crude radiological prevalence of 4.2%, (e) a true anatomical prevalence of 9.6%, (f) a significantly higher frequency in persons of black ancestry than in persons of white, Native American and Middle Eastern ancestries (OR ≈ 3), (g) significantly higher unilateral and bilateral frequencies in black ancestry (OR of 2 and 4, respectively), (h) nonsignificant interactions of OA frequency with gender and side. The commonest type of OA was the meso-acromion type (76.6%). Degenerative changes were present in 66.6% of OAs. The results of this evidence-based anatomical review support a genetic basis for OA rather than the mechanical trauma-induction hypothesis.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  anatomy; evidence-based medicine; os acromiale

Mesh:

Year:  2013        PMID: 24302513     DOI: 10.1002/ca.22343

Source DB:  PubMed          Journal:  Clin Anat        ISSN: 0897-3806            Impact factor:   2.414


  16 in total

1.  Appraising the methodological quality of cadaveric studies: validation of the QUACS scale.

Authors:  J Wilke; F Krause; D Niederer; T Engeroff; F Nürnberger; L Vogt; W Banzer
Journal:  J Anat       Date:  2015-04-07       Impact factor: 2.610

2.  Arthroscopic Excision of a Symptomatic Meso-acromiale.

Authors:  William B Stetson; J Alex McIntyre; Genevieve R Mazza
Journal:  Arthrosc Tech       Date:  2017-02-13

3.  Acromion morphology and bone mineral density distribution suggest favorable fixation points for anatomic acromioclavicular reconstruction.

Authors:  Andreas Voss; Felix Dyrna; Andrea Achtnich; Alex Hoberman; Elifho Obopilwe; Andreas B Imhoff; Augustus D Mazzocca; Knut Beitzel
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-04-22       Impact factor: 4.342

Review 4.  Os acromiale: frequency and a review of 726 shoulder MRI.

Authors:  C Rovesta; M C Marongiu; A Corradini; P Torricelli; G Ligabue
Journal:  Musculoskelet Surg       Date:  2017-02-25

5.  Management of symptomatic os acromiale: a survey of the American shoulder and elbow surgeons.

Authors:  Steven Horton; Michael P Smuda; Julio J Jauregui; Vidushan Nadarajah; Mohit N Gilotra; Ralph Frank Henn; Syed Ashfaq Hasan
Journal:  Int Orthop       Date:  2019-01-03       Impact factor: 3.075

Review 6.  The prevalence of the extensor indicis tendon and its variants: a systematic review and meta-analysis.

Authors:  Kaissar Yammine
Journal:  Surg Radiol Anat       Date:  2014-08-06       Impact factor: 1.246

7.  Bilateral bony fusion around the supraspinatus muscle inducing muscle hypoplasia and shoulder pain.

Authors:  YeNa Son; Kyung Nam Ryu; Wook Jin; Ji Seon Park; So Young Park
Journal:  Skeletal Radiol       Date:  2016-12-14       Impact factor: 2.199

8.  Evidence-based anatomy.

Authors:  Kaissar Yammine
Journal:  Clin Anat       Date:  2014-05-02       Impact factor: 2.414

9.  Prebending of osteosynthesis plate using 3D printed models to treat symptomatic os acromiale and acromial fracture.

Authors:  Hanne Beliën; Hanne Biesmans; Anny Steenwerckx; Eric Bijnens; Carl Dierickx
Journal:  J Exp Orthop       Date:  2017-10-24

10.  The unstable os acromiale: a cause of pain in the young athlete.

Authors:  Antonio Arenas-Miquelez; Ralph Hertel
Journal:  JSES Int       Date:  2020-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.